Opiant Pharmaceuticals to Present at the 2021 Jefferies Virtual Healthcare Conference
Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) announced that CEO Dr. Roger Crystal will present at the Jefferies Virtual Healthcare Conference on June 3, 2021, from 3:30-3:55 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) announced that CEO Dr. Roger Crystal will present at the Jefferies Virtual Healthcare Conference on June 3, 2021, from 3:30-3:55 PM ET. The conference will include 1x1 investor meetings, and a live webcast of the presentation will be accessible on Opiant’s website in the Investors section. A replay of the webcast will be available for 30 days post-event. Opiant specializes in developing medications for addictions and drug overdoses, prominently known for NARCAN® Nasal Spray.
Details
News Market Reaction – OPNT
The recorded move for OPNT in the trading session of this news was -4.18%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANTA MONICA, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, announced today that its Chief Executive Officer, Dr. Roger Crystal, will present at the Jefferies Virtual Healthcare Conference, from 3:30-3:55pm ET on Thursday, June 3, 2021. Opiant will also host 1x1 investor meetings during the conference.
A live webcast of the presentation will be available under ‘Events & Presentations’ in the Investors section of the Opiant website: www.opiant.com. A replay of the webcast will be available for 30 days following the conclusion of the live presentation broadcast.
About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
For more information visit: www.opiant.com.
Investor Relations Contact:
Ben Atkins
VP of Corporate Communications and Investor Relations
Batkins@opiant.com
(310) 598-5410
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.